Description
Sermorelin research overview
Sermorelin is a synthetic peptide amide corresponding to residues 1-29 of growth hormone-releasing hormone (GHRH). This amino-terminal fragment is also known as GRF 1-29. In laboratory models, Sermorelin is used as a research compound to investigate GHRH-receptor binding, pituitary signaling, and related G-protein-coupled receptor pathways.
Identity and specifications
- ICN: 1-11-219
- Alternate names: Sermorelin; GRF 1-29; GHRH (1-29)
- Strength: 15mg
- CAS Number: 86168-78-7
- Formula: C149H246N44O42S
- Molecular weight: 3358.0 g/mol
Research applications
Sermorelin can serve as laboratory reference material in receptor-signaling and peptide-response experiments. Experimental conditions, controls, and analytical methods should be determined by qualified researchers.
Storage and handling
Store in a cool, dry place at -20°C and protect from light.
Sermorelin FAQ
What does GRF 1-29 mean?
It identifies the first 29 amino-acid residues of GHRH represented by the Sermorelin peptide.
Is this a consumer product?
No. This material is offered only for laboratory and in vitro research—not for human or veterinary use, consumption, or therapeutic application.
Documentation
Published batch documentation is listed on this product page when available. Check the COA Library for current and archived records.
